abt-869
Showing 1 - 10 of 10
Solid Tumor Trial (ABT-869)
Completed
- Solid Tumor
- ABT-869
- (no location specified)
Nov 17, 2017
Advanced Solid Tumors Trial (ABT-869)
Completed
- Advanced Solid Tumors
- ABT-869
- (no location specified)
Nov 17, 2017
Advanced or Metastatic NSCLC Trial in Worldwide (ABT-869, Placebo for ABT-869, Carboplatin)
Completed
- Advanced or Metastatic Non-Small Cell Lung Cancer
- ABT-869
- +3 more
-
Chandler, Arizona
- +36 more
Apr 19, 2013
Advanced Colorectal Cancer, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Worldwide (ABT-869, bevacizumab,
Completed
- Advanced Colorectal Cancer
- +2 more
- ABT-869
- +4 more
-
Chapel Hill, North Carolina
- +45 more
May 7, 2013
Metastatic Breast Cancer Trial in San Francisco, Harvey, Durango, DGO. (ABT-869, paclitaxel, Placebo for ABT-869)
Completed
- Metastatic Breast Cancer
- ABT-869
- +2 more
-
San Francisco, California
- +2 more
Jan 23, 2013
Advanced Hepatocellular Carcinoma Trial in Worldwide (ABT-869)
Completed
- Advanced Hepatocellular Carcinoma
- ABT-869
-
Philadelphia, Pennsylvania
- +5 more
Jan 2, 2013
Advanced Renal Cell Carcinoma Trial in Canada, United States (ABT-869)
Completed
- Advanced Renal Cell Carcinoma
- ABT-869
-
Sacramento, California
- +12 more
Jan 2, 2013
Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide
Terminated
- Hepatocellular Carcinoma Non-resectable
- +12 more
- ABT-869
- Sorafenib
-
Beverly Hills, California
- +162 more
Sep 7, 2012